-transparent.png){kind=logo}
Using brain microdialysis in awake rats effects of risperidone, ritanserin, buspirone, sulpiride and 5-methoxy-N,N-dimethyltryptamine (MeODMT) on striatal dopamine (DA) release and metabolism were studied. Risperidone, sulpiride and buspirone increased levels of DA, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Ritanserin failed to affect DA release, while increased DOPAC and HVA levels. MeODMT had no effect on striatal DA release and metabolism. Possible interaction between DA and serotonin systems is discussed.
Related Publications
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
February 1985,
The Journal of neuroscience : the official journal of the Society for Neuroscience,
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
January 1990,
Brain research,
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
January 2002,
Synapse (New York, N.Y.),
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
February 1988,
The American journal of physiology,
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
October 1984,
European journal of pharmacology,
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
November 1991,
Neuropharmacology,
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
January 1985,
The Kurume medical journal,
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
August 2015,
Life sciences,
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
November 1992,
Neuroscience letters,
M B Bogdanov, and
R R Gaĭnetdinov, and
V S Kudrin, and
O S Medvedev, and
A V Val'dman
April 1998,
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
